Peter Neumann

11PUBLICATIONS
17CO-AUTHORS
Economic models and forecastingPharmacology and pharmaceutical sciences not elsewhere classifiedFamily carePharmaceutical delivery technologiesBusiness ethics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 22, 2026
Cost-effectiveness thresholds used in the United States vs most favored nations.

|Jul 28, 2025
What drug characteristics explain the wide range of manufacturer rebates?

Molly T Beinfeld, Fariel LaMountain, Glenn Phillips

|Dec 12, 2024
Food for thought: more explicit guidance for inclusion of caregiver perspectives in health technology assessment.

Siobhan Bourke, Chris Skedgel, Yasmina Martí-Gil

|Aug 30, 2023
Improving Food and Drug Administration-Centers for Medicare and Medicaid Services Coordination for Drugs Granted Accelerated Approval.

Peter J Neumann, Elliott Crummer, James D Chambers

|May 25, 2023
A review of HTA guidelines on societal and novel value elements.

Rachel Milstein Breslau, Joshua T Cohen, Jose Diaz

|Sep 25, 2019
Comparing the cost-per-QALYs gained and cost-per-DALYs averted literatures.

Peter J Neumann, Jordan E Anderson, Ari D Panzer

Pageof 2

Frequent Collaborators

3 joint publications

Joshua T Cohen

1 joint publications

Rachel Milstein Breslau

1 joint publications

Daniel A Ollendorf

1 joint publications

Sean R Tunis